Huntingtin CAG-expansion mutation results in a dominant negative effect

Area of Science:

• Neurodegenerative diseases
• Genetics
• Molecular biology

Background:

• Huntington's disease (HD) is a fatal neurodegenerative disorder caused by a CAG-expansion mutation in the huntingtin gene (HTT).
• The precise pathological mechanism, whether loss of function or toxic gain of function from the mutant HTT protein, remains debated.
• Understanding the underlying mechanism is crucial for developing effective therapeutic strategies against HD.

Purpose of the Study:

• To investigate the distinct contributions of wild-type and mutant huntingtin (HTT) gene expression to Huntington's disease (HD) phenotypes.
• To differentiate between loss-of-function and dominant-negative mechanisms in HD pathogenesis.
• To elucidate the molecular basis of mutant HTT's deleterious effects.

Main Methods:

• Utilized isogenic human embryonic stem cells with genetically modulated wild-type or mutant HTT expression.
• Employed highly reproducible and quantifiable in vitro micropattern-based assays to assess HD-specific phenotypes.
• Compared phenotypes resulting from HD mutation, HTT depletion, and varying levels of wild-type HTT expression.

Main Results:

• Observed comparable phenotypes between HD mutation and HTT depletion in vitro.
• Found that halving wild-type HTT levels did not fully recapitulate HD phenotypes, challenging a simple loss-of-function model.
• Demonstrated that expressing CAG-expanded HTT in non-HD cells induced HD-like phenotypes, similar to HTT depletion.

Conclusions:

• Mutant huntingtin (HTT) protein exerts a dominant-negative effect on wild-type HTT function, rather than solely through loss of function.
• Complementation with additional wild-type HTT ameliorated HD-associated phenotypes, supporting a dominant-negative mechanism.
• Elucidating the molecular basis of this dominant-negative effect is key for developing targeted clinical strategies for Huntington's disease.